Bristol Myers Squibb Price to Free Cash Flow Ratio 2006-2021 | BMY

Historical price to free cash flow ratio values for Bristol Myers Squibb (BMY) since 2006. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bristol Myers Squibb Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2021-12-03 56.32 8.60
2021-09-30 59.17 $6.55 9.03
2021-06-30 65.79 $5.19 12.67
2021-03-31 62.15 $5.84 10.64
2020-12-31 60.60 $5.89 10.29
2020-09-30 58.00 $5.44 10.66
2020-06-30 56.14 $6.01 9.34
2020-03-31 52.79 $5.24 10.07
2019-12-31 60.36 $4.31 14.01
2019-09-30 47.30 $5.33 8.88
2019-06-30 41.93 $4.52 9.28
2019-03-31 43.73 $3.89 11.24
2018-12-31 47.21 $3.74 12.64
2018-09-30 56.02 $2.26 24.83
2018-06-30 49.59 $2.50 19.86
2018-03-31 56.31 $2.78 20.23
2017-12-31 54.21 $2.55 21.22
2017-09-30 56.04 $2.68 20.92
2017-06-30 48.65 $2.43 20.05
2017-03-31 47.14 $1.72 27.44
2016-12-31 50.32 $1.10 45.87
2016-09-30 46.11 $0.82 56.53
2016-06-30 62.90 $0.35 177.78
2016-03-31 54.35 $0.19 281.44
2015-12-31 58.18 $0.77 76.02
2015-09-30 49.79 $0.64 78.17
2015-06-30 55.32 $0.94 58.73
2015-03-31 53.31 $1.56 34.11
2014-12-31 48.79 $1.57 31.07
2014-09-30 41.74 $2.07 20.17
2014-06-30 39.27 $2.15 18.25
2014-03-31 41.76 $2.44 17.13
2013-12-31 42.73 $1.81 23.61
2013-09-30 36.68 $1.43 25.68
2013-06-30 35.14 $3.56 9.88
2013-03-31 32.12 $3.30 9.72
2012-12-31 25.14 $3.79 6.64
2012-09-30 25.78 $4.19 6.15
2012-06-30 27.19 $2.46 11.04
2012-03-31 25.27 $2.52 10.02
2011-12-31 26.13 $2.61 10.03
2011-09-30 23.03 $2.71 8.51
2011-06-30 21.26 $2.48 8.57
2011-03-31 19.18 $2.40 8.00
2010-12-31 18.74 $2.36 7.96
2010-09-30 19.19 $2.37 8.10
2010-06-30 17.45 $2.24 7.77
2010-03-31 18.44 $2.00 9.21
2009-12-31 17.23 $1.97 8.76
2009-09-30 15.18 $1.28 11.83
2009-06-30 13.30 $1.30 10.25
2009-03-31 14.16 $1.43 9.91
2008-12-31 15.02 $1.65 9.09
2008-09-30 13.09 $1.83 7.16
2008-06-30 12.70 $1.46 8.68
2008-03-31 12.99 $1.42 9.13
2007-12-31 15.98 $1.33 12.03
2007-09-30 17.21 $1.11 15.44
2007-06-30 18.68 $1.24 15.09
2007-03-31 16.26 $1.15 14.12
2006-12-31 15.26 $0.81 18.94
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $125.010B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
QIAGEN (QGEN) Netherlands $12.357B 20.93
Biohaven Pharmaceutical Holding (BHVN) United States $6.783B 0.00
Arcus Biosciences (RCUS) United States $3.105B 0.00
Emergent Biosolutions (EBS) United States $2.254B 8.10
ADC Therapeutics SA (ADCT) Switzerland $1.478B 0.00
Myovant Sciences (MYOV) United Kingdom $1.368B 0.00
Zymeworks (ZYME) Canada $0.861B 0.00
Ambrx Biopharma (AMAM) United States $0.337B 0.00
SQZ Biotechnologies (SQZ) United States $0.319B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.90